March 20, 2009
Pharmacosmos participates in the 10th Annual NATA Symposium
(Network for Advancements of Transfusion Alternatives). The NATA
Symposium is will take place on April 16th to 17th 2009 in Linz,
Austria.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.